Clinical Trial Update: Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 bioequivalence study evaluating clopidogrel 300 mg tablets under fasting conditions. The study was sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease
• Peripheral Artery Disease
• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Fasting | Phase 1 | Status: COMPLETED